# Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

> **NCT02716714** · PHASE4 · COMPLETED · sponsor: **Korea University** · enrollment: 77 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** ingenol mebutate gel 0.015%
- **DRUG:** ingenol mebutate gel 0.05%

## Key facts

- **NCT ID:** NCT02716714
- **Lead sponsor:** Korea University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02716714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02716714, "Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02716714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*